News

BMJ21h
Encephalitis as an immune-related adverse event
Correspondence to Dr Shigeaki Suzuki, Department of Neurology, Keio University School of Medicine, Tokyo 160-8582, Japan; sgsuzuki{at}z3.keio.jp If you wish to reuse ...
BMJ3d
Stroke imaging prior to thrombectomy in the late window: results from a pooled multicentre analysis
Background and purpose Collateral assessment using CT angiography is a promising modality for selecting patients for endovascular thrombectomy (EVT) in the late window (6–24 hours). The outcome of ...
BMJ5d
Clinical management of spasticity
Correspondence to: Professor Alan J Thompson Institute of Neurology, Queen Square, London WC1N 3BG, UK; a.thompsonion.ucl.ac.uk Spasticity is a common symptom seen in many neurological conditions, ...
BMJ2d
When neglect is neglected: NIHSS observational measure lacks sensitivity in identifying post-stroke unilateral neglect
Correspondence to Professor Nele Demeyere, Department of Experimental Psychology, Radcliffe Observatory Quarter, Cognitive Neuropsychology Centre, University of Oxford, Oxford, OX2 6GG, UK; ...
BMJ5d
Long-term outcomes of moyamoya disease versus atherosclerosis-associated moyamoya vasculopathy using high-resolution MR vessel wall imaging
Objectives We aimed to compare the long-term outcomes and surgical benefits between moyamoya disease (MMD) and atherosclerosis-associated moyamoya vasculopathy (AS-MMV) using high-resolution MRI ...
BMJ5d
Pain and the immune system: emerging concepts of IgG-mediated autoimmune pain and immunotherapies
The immune system has long been recognised important in pain regulation through inflammatory cytokine modulation of peripheral nociceptive fibres. Recently, cytokine interactions in brain and spinal ...
BMJ4d
Cyproterone acetate and risk of meningioma: a nationwide cohort study
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be ...
BMJ7d
Environmental multiple sclerosis (MS) risk factors, genetic MS risk, and brain development in a general paediatric population
Background Neuroaxonal loss occurs in the early stages of multiple sclerosis (MS), but whether it results from early inflammatory brain damage or an ongoing neurodegenerative process remains unclear.
BMJ5d
Contribution of basal ganglia activity to REM sleep disorder in Parkinson’s disease
Background Rapid eye movement (REM) sleep behaviour disorder (RBD) is one of the most common sleep problems and represents a key prodromal marker in Parkinson’s disease (PD). It remains unclear ...
BMJ5d
Whole-exome sequencing identified novel KIF5A mutations in Chinese patients with amyotrophic lateral sclerosis and Charcot-Marie-Tooth type 2
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be ...
BMJ6d
Disentangling the multiple links between renal dysfunction and cerebrovascular disease
Correspondence to Dr Dearbhla Kelly, Centre for the Prevention of Stroke and Dementia, Nuffield Department of Clinical Neurosciences, John Radcliffe Hospital, Oxford OX3 9DU, UK; ...
BMJ6d
Mastering the art: approaches to diagnosis and management of functional neurological disorders in Irish neurology
Functional Neurological disorder (FND) is a common, disabling condition which is often seen in Neurology Clinics. There are significant challenges associated with making the diagnosis accurately and ...